Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors

    NEXT STORY
    Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference
    PREV STORY
    The global medical headwalls market is expected to reach US$ 1,318.68 Mn in 2027 from US$ 826.80 Mn in 2018
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    North American Partners in Anesthesia provides critical services to AdvantageCare Physicians patients in East New York, Brooklyn

    author_avatar
    NASDAQ Market News

    athenahealth Appoints New CFO

    WATERTOWN, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider ...

    author_avatar
    NASDAQ Market News

    Cerner Expands EHR Across Dignity Health Enterprise

    KANSAS CITY, Mo., March 02, 2016 (GLOBE NEWSWIRE) -- Cerner, a global leader in ...

    author_avatar
    NASDAQ Market News